Fentanyl Addiction

What fentanyl is and how it entered the drug supply

Fentanyl is a synthetic opioid originally developed in 1960 for use in anesthesia and the management of severe or chronic pain. Pharmaceutical fentanyl is still prescribed as transdermal patches, lozenges, and injectable formulations for cancer pain and perioperative analgesia. The fentanyl driving the current overdose crisis is different: it is illicitly manufactured, predominantly produced outside the United States, and has infiltrated virtually every segment of the illicit drug supply.

Illicit fentanyl and its analogues are now found mixed into heroin, pressed into counterfeit pills designed to look exactly like legitimate prescription oxycodone, Xanax, Adderall, or other medications, and increasingly present in cocaine and methamphetamine supplies. According to CDC data, synthetic opioids including fentanyl are responsible for the vast majority of overdose deaths in the United States. The problem is not limited to people who intentionally use opioids; many fentanyl fatalities involve people who had no idea the drug they were taking contained fentanyl.

Illicitly manufactured fentanyl analogues include carfentanil (roughly 100 times more potent than fentanyl itself), acetylfentanyl, and others, all with varying potencies and onset speeds. The extreme potency means that minuscule variations in concentration across a batch of pills or powder translate into an unpredictable gap between a recreational dose and a lethal one.

Why fentanyl is so dangerous: three lethal properties

Fentanyl's extraordinary danger relative to other opioids comes from three properties that combine to make it uniquely lethal even to people with high opioid tolerance.

• Extreme potency: the CDC lists a lethal dose of illicit fentanyl at approximately 2 milligrams for a person without opioid tolerance, an amount invisible to the naked eye
• Unpredictable concentration: illicit batches are not uniformly mixed, so one pill in a batch may contain a sub-threshold dose while the next contains a fatal amount, a phenomenon sometimes called hot spots
• Rapid onset: fentanyl is highly lipid-soluble, crossing the blood-brain barrier faster than heroin, producing respiratory depression that can occur before a person realizes the dose is too high
• Fentanyl can also accumulate in fatty tissue, extending the duration of effect and complicating withdrawal and buprenorphine induction timing
• Because of its potency, standard naloxone doses that reverse heroin overdose may be insufficient for fentanyl overdose, requiring multiple doses

Harm reduction: fentanyl test strips and overdose prevention

Because fentanyl contamination is now widespread in the illicit drug supply, harm reduction measures are relevant for anyone using illicit substances, not only people who use opioids intentionally. SAMHSA endorses fentanyl test strips as an evidence-based harm reduction tool. They detect the presence of fentanyl in drugs before use and can reveal contamination the person never expected.

Carrying naloxone (Narcan) is now recommended for anyone who uses substances, anyone who knows someone who does, and anyone in a household where illicit drugs may be present. Both New Jersey and North Carolina have programs that distribute naloxone to the public. Avoiding using alone eliminates the most common context in which a fentanyl overdose becomes fatal because no one is present to respond.

The Archangel Centers incorporates harm reduction into our fentanyl treatment programming in both New Jersey and North Carolina. We provide naloxone education, discuss test strip use, and help clients and families build safety plans. Harm reduction is not an endorsement of drug use; it is a clinical tool that keeps people alive long enough to access and benefit from treatment.

Recognizing and responding to a fentanyl overdose

A fentanyl overdose can progress to death within minutes because respiratory depression is rapid and severe. Knowing the signs and acting immediately is the difference between life and death.

• Slow, shallow, stopped, or gurgling breathing
• Blue or grayish discoloration of the lips, fingertips, or face (cyanosis)
• Pale, clammy, cold skin
• Pinpoint (extremely small) pupils
• Unresponsive to voice, touch, or sternal rub
• Call 911 immediately: do not wait to see if the person revives on their own
• Administer naloxone: give one spray in one nostril, wait 2-3 minutes, repeat if no response; multiple doses are often needed with fentanyl
• If trained, provide rescue breathing while waiting for naloxone to work
• Place the person in the recovery position if breathing resumes to prevent aspiration
• Stay with them until emergency responders arrive; fentanyl's duration can outlast a single naloxone dose

Fentanyl use disorder: how it differs clinically

Fentanyl use disorder is diagnosed using the same DSM-5 opioid use disorder criteria as other opioid disorders, but it presents several clinical features that distinguish it in treatment planning. The extremely high potency means that people develop very high tolerance relative to morphine-equivalent dosing, which has implications for the buprenorphine doses needed to adequately suppress withdrawal and cravings. Under-dosing buprenorphine for fentanyl dependence is a common clinical error that leads to poor outcomes.

Withdrawal from fentanyl can be more protracted and less predictable than withdrawal from shorter-acting opioids because fentanyl accumulates in fatty tissue and is released slowly. This can extend the acute withdrawal phase and make buprenorphine induction timing more complex. Precipitated withdrawal, which is a sudden severe withdrawal reaction triggered by taking buprenorphine while fentanyl is still occupying receptors, is a real risk that requires careful clinical management. Low-dose buprenorphine induction protocols have emerged as one approach to managing this risk.

Co-occurring stimulant use and significant trauma loads are particularly prevalent in the clinical population with fentanyl use disorder, requiring integrated dual diagnosis care.

Treatment for fentanyl use disorder

The Archangel Centers is an outpatient provider offering PHP, IOP, and standard outpatient care in New Jersey and North Carolina. We do not provide medical detox, inpatient, or residential treatment. When a client needs medically supervised withdrawal management, we coordinate that placement with licensed partners, then bring them into our outpatient programming once they are stable.

Medication-assisted treatment is the standard of care for fentanyl use disorder and is strongly recommended by ASAM, NIDA, and the Surgeon General. Buprenorphine (Suboxone sublingual film or Sublocade monthly injectable) suppresses withdrawal and cravings and is the most commonly used first-line medication. The timing of induction requires careful clinical judgment given fentanyl's tissue accumulation. Naltrexone (Vivitrol monthly injectable) is an option for clients who have completed medically supervised withdrawal and have appropriate abstinence before starting.

• Buprenorphine (Suboxone, Sublocade): first-line MAT for fentanyl use disorder, dosed to suppress cravings adequately
• Naltrexone (Vivitrol): opioid antagonist option for clients who have completed withdrawal and have an appropriate abstinence window
• Naloxone education and take-home distribution guidance as part of every fentanyl treatment episode
• Overdose safety planning with clients and families
• CBT, DBT, trauma-informed therapy, and EMDR for the behavioral and psychological dimensions
• Dual diagnosis care for co-occurring depression, anxiety, PTSD, and stimulant use
• PHP, IOP, and outpatient continuing care with regular clinical reassessment

Insurance, cost, and getting started

Federal parity law requires most major insurance plans, including Medicaid in New Jersey and North Carolina, to cover medically necessary treatment for opioid use disorder including fentanyl. The Archangel Centers verifies insurance benefits for free, typically within minutes, and provides a clear explanation of your real out-of-pocket costs before you commit. Same-week placement is often available.

If you are uninsured or underinsured, self-pay options and sliding-scale fees are reviewed on an individual basis. Waiting for financial certainty before seeking help for fentanyl use disorder is medically dangerous given the overdose risk. The intake process starts with a free, confidential call.